Clinical Trials Browser

Neoplasms × BNT162 Vaccine × Clear all

NCT05016622 2024-07-31

Booster Dose Trial

Phase 2 Terminated

106 enrolled 39 charts

COVID-19, Neoplasms

NCT05075538 2024-01-17

I-SPARC

Phase 4 Terminated

COVID-19, Neoplasms